Tianjin Ringpu Bio Tech Cash Flow Reinvestment Rate
Tianjin Ringpu Bio Tech cash flow reinvestment rate. Tianjin Ringpu Bio Tech (300119) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥23.24 Million (capex CN¥23.24 Million ) from operating cash flow of CN¥105.02 Million. Explore 300119 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tianjin Ringpu Bio Tech (2007–2025)
Cash flow reinvestment rate of Tianjin Ringpu Bio Tech from 2007 to 2025. Historical reinvestment intensity for Tianjin Ringpu Bio Tech across 19 annual periods. Explore Tianjin Ringpu Bio Tech (300119) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Tianjin Ringpu Bio Tech Cash Flow Reinvestment Rate by Year (2007–2025)
Tianjin Ringpu Bio Tech cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Tianjin Ringpu Bio Tech. For the full cash flow conversion analysis, see Tianjin Ringpu Bio Tech operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.79x | CN¥531.63 Million | CN¥297.53 Million | CN¥176.10 Million | ▲ +429.0% |
| 2024 | 0.34x | CN¥248.44 Million | CN¥735.55 Million | CN¥185.34 Million | ▼ -68.5% |
| 2023 | 1.07x | CN¥405.46 Million | CN¥378.20 Million | CN¥244.48 Million | ▼ -74.2% |
| 2022 | 4.15x | CN¥1.62 Billion | CN¥389.49 Million | CN¥372.43 Million | ▲ +142.5% |
| 2021 | 1.71x | CN¥655.02 Million | CN¥382.63 Million | CN¥305.88 Million | ▲ +148.8% |
| 2020 | 0.69x | CN¥267.23 Million | CN¥388.44 Million | CN¥259.17 Million | ▼ -37.0% |
| 2019 | 1.09x | CN¥418.70 Million | CN¥383.61 Million | CN¥229.70 Million | ▲ +17.2% |
| 2018 | 0.93x | CN¥162.91 Million | CN¥174.88 Million | CN¥112.45 Million | ▼ -29.9% |
| 2017 | 1.33x | CN¥142.90 Million | CN¥107.57 Million | CN¥108.87 Million | ▼ -52.3% |
| 2016 | 2.78x | CN¥578.12 Million | CN¥207.67 Million | CN¥128.13 Million | ▲ +35.3% |
| 2015 | 2.06x | CN¥463.56 Million | CN¥225.27 Million | CN¥151.10 Million | ▲ +44.3% |
| 2014 | 1.43x | CN¥183.11 Million | CN¥128.37 Million | CN¥183.11 Million | ▼ -49.7% |
| 2013 | 2.84x | CN¥251.60 Million | CN¥88.68 Million | CN¥251.60 Million | ▲ +52.4% |
| 2012 | 1.86x | CN¥167.37 Million | CN¥89.92 Million | CN¥167.37 Million | ▼ -9.1% |
| 2011 | 2.05x | CN¥184.82 Million | CN¥90.29 Million | CN¥184.82 Million | ▲ +383.2% |
| 2010 | 0.42x | CN¥47.79 Million | CN¥112.82 Million | CN¥47.79 Million | ▼ -12.7% |
| 2009 | 0.49x | CN¥31.34 Million | CN¥64.59 Million | CN¥31.34 Million | ▲ +68.0% |
| 2008 | 0.29x | CN¥19.66 Million | CN¥68.07 Million | CN¥19.66 Million | ▼ -67.5% |
| 2007 | 0.89x | CN¥16.99 Million | CN¥19.15 Million | CN¥16.99 Million | — |